Burkitt lymphoma is reported by the World Health Organization as a highly aggressive B-cell lymphoma. Three clinical variants of Burkitt lymphoma are recognized (endemic, sporadic, immunodeficiency-associated), which differ in geographic distribution, clinical presentation, and association with infectious agents and cell biology. The tumor is composed by monomorphic medium-sized B-cells with basophilic cytoplasm, numerous mitotic figures, and an extremely high proliferation rate (Ki-67-index >95 %). A “starry sky” pattern is usually present, due to numerous benign macrophages that have ingested apoptotic tumor cells. Tumor cells express membrane IgM with light chain restriction and B-cell-associated antigens CD19, CD20, CD22, and CD79a. Chr...
rus-positive endemic Burkitt's lymphoma (Bl) have been examined for cell surface phenotype, bot...
Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear....
Burkitt lymphoma (BL) is classified into 3 clinical subsets: endemic, sporadic, and immunodeficiency...
Burkitt lymphoma is reported by the World Health Organization as a highly aggressive B-cell lymphoma...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
In this paper, the authors evaluate the historical evolution of the definition of Burkitt's lymphoma...
Burkitt lymphoma is a cancer of the lymphatic system (in particular, B lymphocytes). It was named af...
Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear....
6In this paper, the authors evaluate the historical evolution of the definition of Burkitt's lymphom...
BACKGROUND: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear...
phoma classification gives Burkitt-like lymphoma (BLL) provisional status, leav-ing unresolved the d...
The World Health Organisation classification reports three subcategories of Burkitt's lymphoma (BL)-...
Burkitt's lymphoma, a pathological entity initially described in Africa, is the most common childhoo...
Phenotype / cell stem origin Pan-B antigens positive; TdT-, CD10+; CD5-; sIgM+. The cell of origin i...
rus-positive endemic Burkitt's lymphoma (Bl) have been examined for cell surface phenotype, bot...
Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear....
Burkitt lymphoma (BL) is classified into 3 clinical subsets: endemic, sporadic, and immunodeficiency...
Burkitt lymphoma is reported by the World Health Organization as a highly aggressive B-cell lymphoma...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
In this paper, the authors evaluate the historical evolution of the definition of Burkitt's lymphoma...
Burkitt lymphoma is a cancer of the lymphatic system (in particular, B lymphocytes). It was named af...
Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear....
6In this paper, the authors evaluate the historical evolution of the definition of Burkitt's lymphom...
BACKGROUND: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear...
phoma classification gives Burkitt-like lymphoma (BLL) provisional status, leav-ing unresolved the d...
The World Health Organisation classification reports three subcategories of Burkitt's lymphoma (BL)-...
Burkitt's lymphoma, a pathological entity initially described in Africa, is the most common childhoo...
Phenotype / cell stem origin Pan-B antigens positive; TdT-, CD10+; CD5-; sIgM+. The cell of origin i...
rus-positive endemic Burkitt's lymphoma (Bl) have been examined for cell surface phenotype, bot...
Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear....
Burkitt lymphoma (BL) is classified into 3 clinical subsets: endemic, sporadic, and immunodeficiency...